Puma Biotechnology Inc (NASDAQ:PBYI)
| 3.00 Delayed Data As of Dec 03 |  -0.01 / -0.33%Today’s Change | 2.85 Today|||52-Week Range 14.14 | -70.76% Year-to-Date |
Latest PBYI News | Press Releases
| Do Options Traders Know Something About Puma (PBYI) Stock We Don't? Dec 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.01 |
| Today’s open | 3.07 |
| Day’s range | 2.87 - 3.07 |
| Volume | 40,217 |
| Average volume (3 months) | 574,806 |
| Market cap | $122.7M |
Data as of 3:59pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | +22.26% |
| Earnings growth (this year) | +42.12% |
| Earnings growth (next 5 years) | +33.70% |
| Revenue growth (last year) | -17.32% |
| P/E ratio | NM |
| Price/Sales | 1.80 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTNPalatin Technologies... | -0.03 | -5.27% |
| KZIAKazia Therapeutics L... | -0.72 | -7.19% |
| SVRASavara Inc | -0.03 | -2.75% |
| TYMETyme Technologies In... | -0.08 | -9.49% |
Data as of 4:00pm ET, 12/03/2021
Financials
| Next reporting date | March 3, 2022 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $225.1M |
| Annual profit (last year) | -$60.0M |
| Net profit margin | -26.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
